ArticleScientific reports2024

Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level.

Ayobami Akenroye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.